Clinical presentation, associated factors, and course of cutaneous reaction after the booster dose of COVID-19 vaccination
Pattriya Jirawattanadon(Siriraj Hospital), Phumithep Phumariyapong(Siriraj Hospital), Kanokvalai Kulthanan(Siriraj Hospital), Papapit Tuchinda(Siriraj Hospital), Charussri Leeyaphan(Siriraj Hospital), Yanisorn Nanchaipruek(Siriraj Hospital), Thrit Hutachoke(Siriraj Hospital), Sumanas Bunyaratavej(Mahidol University), Pornpan Koomanachai(Siriraj Hospital), Phutsadee Pudchakan(Siriraj Hospital)
Cited by 1
Related Papers
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
Urticaria
|Nature Reviews Disease Primers|2022|368
The global burden of chronic urticaria for the patient and society*
|British Journal of Dermatology|2020|351
Chronic idiopathic urticaria: prevalence and clinical course
|The Journal of Dermatology|2007|184